IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,587,891 | +1.2% | 9,551,852 | +20.3% | 0.01% | 0.0% |
| Q2 2023 | $149,807,307 | +128.5% | 7,938,914 | -53.5% | 0.01% | +100.0% |
| Q1 2023 | $65,575,519 | -62.2% | 17,076,958 | -51.2% | 0.00% | -20.0% |
| Q4 2022 | $173,680,480 | +149.0% | 35,016,226 | +139.9% | 0.01% | +25.0% |
| Q3 2022 | $69,763,000 | -14.8% | 14,594,873 | -19.8% | 0.00% | -20.0% |
| Q2 2022 | $81,898,000 | +25.5% | 18,199,554 | +32.8% | 0.01% | +66.7% |
| Q1 2022 | $65,247,000 | +9.0% | 13,707,389 | +69.9% | 0.00% | 0.0% |
| Q4 2021 | $59,869,000 | +16.5% | 8,068,567 | -11.0% | 0.00% | 0.0% |
| Q3 2021 | $51,403,000 | -27.2% | 9,065,857 | -15.4% | 0.00% | -25.0% |
| Q2 2021 | $70,644,000 | -3.3% | 10,719,931 | +18.8% | 0.00% | 0.0% |
| Q1 2021 | $73,090,000 | +28.7% | 9,023,479 | +2.5% | 0.00% | +33.3% |
| Q4 2020 | $56,785,000 | +76.0% | 8,803,841 | -1.8% | 0.00% | +50.0% |
| Q3 2020 | $32,270,000 | -23.6% | 8,964,006 | -2.4% | 0.00% | -33.3% |
| Q2 2020 | $42,243,000 | +116.4% | 9,183,306 | +60.4% | 0.00% | +50.0% |
| Q1 2020 | $19,525,000 | -28.5% | 5,725,865 | +7.1% | 0.00% | 0.0% |
| Q4 2019 | $27,294,000 | +81.6% | 5,346,426 | -13.9% | 0.00% | +100.0% |
| Q3 2019 | $15,027,000 | +134.5% | 6,209,347 | +110.3% | 0.00% | – |
| Q2 2019 | $6,408,000 | -81.3% | 2,952,996 | -76.7% | 0.00% | -100.0% |
| Q1 2019 | $34,275,000 | -11.8% | 12,647,744 | +56.1% | 0.00% | -25.0% |
| Q4 2018 | $38,882,000 | -54.0% | 8,100,371 | -9.3% | 0.00% | -33.3% |
| Q3 2018 | $84,579,000 | -3.4% | 8,931,512 | -0.7% | 0.01% | -14.3% |
| Q2 2018 | $87,532,000 | +15.0% | 8,996,007 | +24.3% | 0.01% | +16.7% |
| Q1 2018 | $76,137,000 | +42.3% | 7,237,248 | -13.3% | 0.01% | +50.0% |
| Q4 2017 | $53,496,000 | +13.2% | 8,345,171 | +35.1% | 0.00% | 0.0% |
| Q3 2017 | $47,260,000 | +60.5% | 6,177,805 | +49.2% | 0.00% | +33.3% |
| Q2 2017 | $29,450,000 | +376.2% | 4,141,583 | +159.1% | 0.00% | +200.0% |
| Q1 2017 | $6,185,000 | +98.6% | 1,598,707 | +4.7% | 0.00% | – |
| Q4 2016 | $3,115,000 | -21.5% | 1,526,398 | +3.1% | 0.00% | – |
| Q3 2016 | $3,967,000 | -57.6% | 1,480,770 | -51.3% | 0.00% | -100.0% |
| Q2 2016 | $9,367,000 | -57.3% | 3,042,041 | +18.1% | 0.00% | -50.0% |
| Q1 2016 | $21,950,000 | -38.3% | 2,576,027 | -1.7% | 0.00% | -50.0% |
| Q4 2015 | $35,548,000 | +14.8% | 2,619,662 | -18.8% | 0.00% | 0.0% |
| Q3 2015 | $30,971,000 | -34.1% | 3,225,865 | -1.3% | 0.00% | -20.0% |
| Q2 2015 | $47,020,000 | +24.2% | 3,269,703 | -22.7% | 0.01% | +25.0% |
| Q1 2015 | $37,863,000 | +97.6% | 4,230,582 | +34.7% | 0.00% | +100.0% |
| Q4 2014 | $19,162,000 | -35.7% | 3,141,312 | +11.6% | 0.00% | -33.3% |
| Q3 2014 | $29,809,000 | -0.8% | 2,815,046 | +11.0% | 0.00% | 0.0% |
| Q2 2014 | $30,049,000 | -22.9% | 2,535,747 | -2.9% | 0.00% | -25.0% |
| Q1 2014 | $38,993,000 | -41.5% | 2,611,643 | -46.1% | 0.00% | 0.0% |
| Q4 2013 | $66,617,000 | +48.5% | 4,845,655 | +83.9% | 0.00% | -33.3% |
| Q3 2013 | $44,855,000 | +4.1% | 2,635,319 | +1.4% | 0.01% | 0.0% |
| Q2 2013 | $43,102,000 | – | 2,598,245 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,477,879 | $37,720,000 | 0.69% |
| QVT Financial LP | 1,375,900 | $4,953,000 | 0.60% |
| RA Capital Management | 7,040,485 | $25,346,000 | 0.46% |
| Birchview Capital, LP | 380,000 | $1,368,000 | 0.46% |
| XTX MARKETS LLC | 18,861 | $68,000 | 0.33% |
| Fernwood Investment Management, LLC | 154,340 | $556,000 | 0.26% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $375,000 | 0.14% |
| Virtus ETF Advisers LLC | 70,213 | $253,000 | 0.13% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,251,458 | $4,505,000 | 0.13% |
| Assenagon Asset Management S.A. | 4,987,334 | $17,954,000 | 0.10% |